| 2026-06-01 |
详情>>
内部人交易：
PYOTT DAVID E I共交易5笔
|
| 2026-04-30 |
详情>>
股本变动：
变动后总股本13351.26万股
|
| 2026-04-30 |
详情>>
业绩披露：
2026年一季报每股收益1.55美元,归母净利润2.06亿美元,同比去年增长458.38%
|
| 2026-04-30 |
财报披露：
美东时间 2026-04-30 盘前发布财报
|
| 2026-04-06 |
股东大会：
将于2026-05-20召开股东大会
会议内容 ▼▲
- 1.To elect three members to our board of directors, as nominated by our board of directors, each to serve as a Class I director for a term ending in 2029, or until a successor has been duly elected and qualified;
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
3.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2026;
4.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2026-02-12 |
详情>>
业绩披露：
2023年年报每股收益-3.52美元,归母净利润-4.4亿美元,同比去年增长61.08%
|
| 2026-02-12 |
详情>>
业绩披露：
2025年年报每股收益2.39美元,归母净利润3.14亿美元,同比去年增长212.79%
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.98美元,归母净利润1.27亿美元,同比去年增长165.50%
|
| 2025-07-31 |
详情>>
业绩披露：
2025年中报每股收益-0.95美元,归母净利润-1.24亿美元,同比去年增长-49.42%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益-0.44美元,归母净利润-5747.9万美元,同比去年增长12.82%
|
| 2025-03-24 |
股东大会：
将于2025-05-08召开股东大会
会议内容 ▼▲
- 1.To elect four members to our board of directors, as nominated by our board of directors, each to serve as a Class III director for a term ending in 2028, or until a successor has been duly elected and qualified;
2.To approve an amendment to our Restated Certificate of Incorporation allowing for officer exculpation;
3.To approve our Second Amended and Restated 2018 Stock Incentive Plan, to, among other things, increase the number of shares authorized for issuance thereunder by 7,000,000 shares;
4.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
5.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2025;
6.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2025-03-21 |
复牌提示：
2025-03-20 15:39:18 停牌，复牌日期 2025-03-21 07:00:00
|
| 2025-02-13 |
详情>>
业绩披露：
2022年年报每股收益-9.3美元,归母净利润-11.31亿美元,同比去年增长-32.64%
|
| 2025-02-13 |
详情>>
业绩披露：
2024年年报每股收益-2.18美元,归母净利润-2.78亿美元,同比去年增长36.82%
|
| 2024-10-31 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.53美元,归母净利润-1.94亿美元,同比去年增长35.71%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-0.66美元,归母净利润-8282.4万美元,同比去年增长81.60%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益-0.52美元,归母净利润-6593.5万美元,同比去年增长62.13%
|
| 2024-04-01 |
股东大会：
将于2024-05-16召开股东大会
会议内容 ▼▲
- 1.To elect four (4) members to our board of directors, as nominated by our board of directors, each to serve as a Class II director for a term ending in 2027, or until a successor has been duly elected and qualified;
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
3.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2024;
4.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2023-04-03 |
股东大会：
将于2023-05-18召开股东大会
会议内容 ▼▲
- 1.To elect four (4) members to our board of directors, as nominated by our board of directors, each to serve as a Class I director for a term ending in 2026, or until a successor has been duly elected and qualified;
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
3.To recommend, in a non-binding “say-on-frequency” vote, the frequency of future advisory “say-on-pay” votes;
4.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2023;
5.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2022-04-05 |
股东大会：
将于2022-05-18召开股东大会
会议内容 ▼▲
- 1.To elect three (3) members to our board of directors, as nominated by our board of directors, each to serve as a Class III director for a term ending in 2025, or until a successor has been duly elected and qualified;
2.To approve Alnylam’s Amended and Restated 2018 Stock Incentive Plan, to, among other things, increase the number of shares authorized for issuance thereunder by 6,000,000 shares;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
4.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2022;
5.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-02 |
股东大会：
将于2021-05-18召开股东大会
会议内容 ▼▲
- 1.To elect four (4) members to our board of directors, as nominated by our board of directors, each to serve as a Class II director for a term ending in 2024, or until a successor has been duly elected and qualified;
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
3.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2021;
4.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2020-03-23 |
股东大会：
将于2020-05-06召开股东大会
会议内容 ▼▲
- 1.To elect three (3) members to our board of directors, as nominated by our board of directors, each to serve as a Class I director for a term ending in 2023, or until a successor has been duly elected and qualified;
2.To approve an amendment to our 2018 Stock Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance thereunder by 7,000,000 shares;
3.To approve an amendment to our Amended and Restated 2004 Employee Stock Purchase Plan, as amended, to increase the number of shares authorized for issuance thereunder from 1,215,789 shares to 1,965,789 shares;
4.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
5.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2020;
6.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2019-03-21 |
股东大会：
将于2019-04-25召开股东大会
会议内容 ▼▲
- 1.To elect four (4) members to our board of directors, as nominated by our board of directors, each to serve as a Class III director for a term ending in 2022, or until a successor has been duly elected and qualified;
2.To approve an amendment to our Restated Certificate of Incorporation to permit the holders of at least a majority of our common stock to call special meetings of the stockholders;
3.To approve an amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 125,000,000 to 250,000,000 shares;
4.To approve, contingent upon the approval of Item 3, an amendment to our 2018 Stock Incentive Plan to, among other things, increase the number of shares of common stock authorized for issuance thereunder by 3,290,000 shares;
5.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
6.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2019;
7.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2018-03-23 |
股东大会：
将于2018-05-10召开股东大会
会议内容 ▼▲
- 1.To elect four (4) members to our board of directors, as nominated by our board of directors, each to serve as a Class II director for a term ending in 2021, or until a successor has been duly elected and qualified;
2.To approve the adoption of our 2018 Stock Incentive Plan;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
4.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2018;
5.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2017-03-17 |
股东大会：
将于2017-05-02召开股东大会
会议内容 ▼▲
- 1.To elect four (4) members to our board of directors, as nominated by our board of directors, each to serve as a Class I director for a term ending in 2020, or until a successor has been duly elected and qualified;
2.To approve our proposed Second Amended and Restated 2009 Stock Incentive Plan, to, among other things, increase the number of shares authorized for issuance thereunder from 11,700,000 shares to 15,480,000 shares;
3.To approve our Amended and Restated 2004 Employee Stock Purchase Plan, to increase the number of shares authorized for issuance thereunder from 715,789 shares to 1,215,789 shares;
4.To approve, on a non-binding advisory basis, the compensation of our named executive officers, as described in the “Compensation Discussion and Analysis,” executive compensation tables and accompanying narrative disclosures in this proxy statement;
5.To recommend, in a non-binding “say-on-frequency” vote, the frequency of future advisory “say-on-pay” votes;
6.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending December 31, 2017;
7.To transact any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|